Clinical Trials for Advanced Lung Cancer

Find clinical trials for advanced lung cancer. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

NCT ID: NCT06892548

This clinical trial is studying a new combination therapy for patients with advanced lung cancer. The treatment includes two investigational drugs: BNT324, which targets a specific protein on cance...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Beverly Hills, California, United States

Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

NCT ID: NCT06713798

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic non-small cell lung cancer (NSCLC) that has certain immune structures called tertiary lymphoid...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Poitiers, , France, Villejuif, , France +3 more

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT ID: NCT06625775

The BREAKER-101 clinical trial is a study looking at a new treatment called BBO-10203 for patients with advanced solid tumors, including certain types of breast and colorectal cancers. This is the ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, New York, New York, United States +13 more

Engage Psychosocial Intervention for Cancer Symptoms

NCT ID: NCT06555588

This clinical trial, called ENGAGE, is designed to help patients with advanced cancer—specifically Stage IV breast, prostate, lung, or colorectal cancer—manage their symptoms better. The study will...

Recruiting

Phase: NA Type: interventional Locations: Durham, North Carolina, United States

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

NCT ID: NCT06945523

This clinical trial is studying a new treatment called CAR-T therapy for patients with advanced lung cancer that tests positive for a specific tumor marker called CEA. Lung cancer, especially non-s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

NCT ID: NCT06992583

This clinical trial is studying a new treatment called targeted anti-CEA CAR-T immunotherapy for patients with advanced lung cancer, particularly those who have run out of other treatment options. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nanjing, Jiangsu, China

Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.

NCT ID: NCT06928922

This clinical trial is testing a new vaccine called BMD006, which is designed to help treat advanced lung cancer and lung metastasis (cancer that has spread to the lungs from other parts of the bod...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Beijing, , China

Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

NCT ID: NCT06903117

This clinical trial is looking at a new treatment for advanced lung cancer that is positive for a specific marker called CEA (carcinoembryonic antigen). This trial is testing a type of therapy call...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer

NCT ID: NCT06228209

The TIER-PC clinical trial is studying a new approach to providing palliative care for patients with advanced heart failure or certain types of advanced cancer. This program aims to deliver the rig...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, New York, New York, United States

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

NCT ID: NCT06791057

This clinical trial is looking at a new way to help patients with advanced lung cancer who are experiencing breathlessness, a common and distressing symptom known as dyspnea. The study will test a ...

Not yet recruiting

Phase: NA Type: interventional Locations: Baltimore, Maryland, United States, Boston, Massachusetts, United States +1 more

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

NCT ID: NCT06768151

This clinical trial is investigating a new treatment called CAR-T cell therapy for people with advanced lung cancer that tests positive for a specific marker known as CEA. Lung cancer is a serious ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

NCT ID: NCT06183762

This clinical trial is studying how patients with advanced lung cancer, specifically those with a certain genetic change called a MET mutation, are being treated in real-life settings. The main goa...

Recruiting

Type: observational Locations: Changsha, Hunan, China

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

NCT ID: NCT06456138

This clinical trial is researching a new treatment approach for patients with advanced non-small cell lung cancer (NSCLC) that have a specific genetic mutation called KRAS. Traditionally, cancers w...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

WTX212A Monotherapy and in Combination With PD -1/PD-L1 Monoclonal Antibody

NCT ID: NCT06106152

This clinical trial is investigating a new treatment called WTX212A for patients with advanced lung cancer. The study aims to understand how well WTX212A works on its own and when used with another...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

NCT ID: NCT06326086

This clinical trial is studying how different treatments for advanced lung cancer—specifically chemotherapy, targeted therapy, and immunotherapy—affect muscle mass and physical performance in patie...

Recruiting

Type: observational Locations: Hat Yai, Songkla, Thailand

TIL Therapy for Patients With Advanced Solid Tumors

NCT ID: NCT06107894

This clinical trial is investigating a new treatment called NEOG-100 for patients with advanced breast cancer and lung cancer. NEOG-100 uses specially modified immune cells, known as tumor infiltra...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions